Ad Header



The Pulse of the Pharmaceutical Industry

  • Filter By Category

  • Filter By Author

ASLAN Pharma Takes on Full License of Atopic Dermatitis Drug in $775 Million-Plus Deal

Singapore-based ASLAN Pharmaceuticals amended the company’s global license agreement with CSL Limited to gain full rights to the fully human monoclonal antibody ASLAN004 being developed for atopic dermatitis and other inflammatory diseases.

Read More »

Optimizing the Precision Blending of Pharmaceutical Tablets

  Tumble blender technology enhances the speed and homogeneous blending of tablets and capsules with trace levels of additives   To meet stringent regulatory requirements, such as the United States Pharmacopeia (USP), National Formulary (NF) or FDA, as well as production and budgetary demands, pharmaceutical manufacturers require high-volume precision blending of formulations on equipment that […]

Read More »

Amicus and Penn Broaden Gene Therapy Collaboration

Cranbury, N.J.-based Amicus Therapeutics and the Perelman School of Medicine at the University of Pennsylvania are expanding their gene therapy collaboration.

Read More »

inVibe Labs Reinvents Market Research, Creates Nuanced Listening Platform Yielding Actionable Insights from Emotional Speech Patterns in Patient and Physician Conversations

inVibe Labs, a market research innovator dedicated to changing the way healthcare organizations listen to their customers, helps healthcare companies better understand the thoughts and feelings of patients and physicians by reading between the lines to uncover meaningful language patterns hidden in plain sight.

Read More »

Bayer to work with Foundation Medicine

Bayer struck a collaboration deal with Roche’s Foundation Medicine Inc. to develop test kits for genetic sequencing of tumor cells to identify cancer patients that benefit from Bayer’s Vitrakvi drug.

Read More »

Orchard Therapeutics Licenses Potentially Life-Changing MPS-I Gene Therapy Program

Orchard Therapeutics secured an exclusive license for an ex vivo autologous hematopoietic stem cell gene therapy program for the treatment of MPS-I developed by SR-Tiget.

Read More »

W2O Announces Investment from New Mountain Capital; Partnership Focused on Making the World a Healthier Place through Marketing Communications

W2O announced a partnership with New Mountain Capital to accelerate continued growth and scale of the company to meet the evolving needs of its clients to most effectively and efficiently communicate with and influence their key stakeholders in an increasingly digital and mobile world.

Read More »

Thrive or die in the omnichannel era

Norm Phillips, EVP and Chief Marketing Officer with BioPharm Communications, explains the challenges and opportunities for pharma and describes advantages they have compared to those in the consumer marketing world, such as identifiable influencers, customer-level data and access/reimbursement insights.

Read More »

EVERSANA acquires Alamo Pharma Services and BexR Logistix Telesales

EVERSANA, a leading independent provider of commercial services to the life science industry, announced the acquisition of Alamo Pharma Services Inc. and BexR Logistix LLC Telesales from Mission Pharmacal Company.

Read More »

Teva Pharm to pay Oklahoma $85 million to settle opioid claims

Teva Pharmaceutical agreed to pay an $85 million settlement with the state of Oklahoma days before the company was set to face trial over allegations that the world’s largest generic manufacturer and other drugmakers helped fuel the U.S. opioid epidemic.

Read More »

Ad Right Top


Extensive pharmaceutical business and marketing intelligence. For back issues, please contact

June 2019 Focus: Payer access, biotech/biopharma, DTC, rare diseases, and more!


Ad Right Bottom